| Trial Identifier: | D961WC00001 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT03553563 |
| Start Date: | July 2018 |
| Primary Completion Date: | December 2022 |
| Study Completion Date: | December 2022 |
| Condition: | Digestive & Intestinal - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| Japanese Translation |
| Country | Location |
|---|---|
| JP | Bunkyo-ku, JP, 113-8519 |
| JP | Bunkyo-ku, JP, 113-8431 |
| JP | Fuji-shi, JP, 417-8567 |
| JP | Izumi-shi, JP, 594-1101 |
| JP | Kagoshima-shi, JP, 890-8520 |
| JP | Kanazawa-shi, JP, 920-8641 |
| JP | Kyoto-shi, JP, 602-8566 |
| JP | Maebashi-shi, JP, 371-8511 |
| JP | Matsumoto-shi, JP, 390-8621 |
| JP | Okayama-shi, JP, 701-1192 |
| JP | Saitama-shi, JP, 339-8551 |
| JP | Sakai-shi, JP, 593-8304 |
| JP | Setagaya-ku, JP, 157-8535 |
| JP | Shinjuku-ku, JP, 160-0023 |
| JP | Takatsuki-shi, JP, 569-8686 |
| JP | Yokohama-shi, JP, 232 8555 |
| JP | Yokohama-shi, JP, 230-8765 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company